Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that competition for early-line use of Amgen/Pfizer's Enbrel and ...
WASHINGTON - The Food and Drug Administration ordered stronger warnings Thursday on four medications widely used to treat rheumatoid arthritis and other serious illnesses, saying they can raise the ...
(Reuters) - Amgen Inc's cheaper version of AbbVie's top-selling arthritis drug Humira is highly similar to the original and should be approved, an advisory panel to the U.S. Food and Drug ...
AbbVie and its longtime blockbuster arthritis drug Humira are now front and center in the Outcome Health trial. Outcome Health was a high-flying Chicago company that made headlines when it raised $488 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback